Publication | Closed Access

Implication of respiratory syncytial virus (RSV) F transgene sequence heterogeneity observed in Phase 1 evaluation of MEDI-534, a live attenuated parainfluenza type 3 vectored RSV vaccine

VaccinationViral EvolutionVaccine DevelopmentVectored Rsv VaccineMedicineVaccine TargetImmunologyVirologyRespiratory Syncytial VirusVaccine ResearchPhase 1Viral Genetics